FCM
ADAP

Farallon Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Farallon Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,515,762
Closed -$20.1M – 135
2020
Q3 		$20.1M Buy
2,515,762
+15,762
+0.6% +$126K 0.14% 83
2020
Q2 		$25M Buy
+2,500,000
New +$25M 0.2% 80
2015
Q3 		– Sell
-250,000
Closed -$4.58M – 81
2015
Q2 		$4.58M Buy
+250,000
New +$4.58M 0.06% 81